Ohio Doctor Loses DEA Registration After State Action
Published Date: 7/10/2026
Notice
Summary
Dr. Timothy Genetta from Ohio lost his DEA registration because he no longer has the legal right to handle controlled substances in his state. He didn’t ask for a hearing, so the DEA canceled his registration by default. This means he must stop prescribing or handling these drugs immediately, with no money or timing benefits for him.
Analyzed Economic Effects
2 provisions identified: 1 benefits, 1 costs, 0 mixed.
DEA Registration Revoked for Dr. Genetta
The DEA revoked Timothy Genetta, D.O.'s Certificate of Registration No. FG3579503 after finding he is not licensed to practice medicine in Ohio and therefore not authorized to handle controlled substances. The Order also denies any pending applications to renew, modify, or obtain additional DEA registration in Ohio; the Order is effective August 10, 2026.
15-Day Reconsideration Opportunity
The Order states that the registrant may dispute the Agency's finding that he lacks a license by filing a properly supported motion for reconsideration within fifteen calendar days of the date of this Order. Any such motion and response must be filed and served by email as described in the Order.
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-11526 — Implementation of the Substance Use-Disorder Prevention That Promotes Opioid Recovery and Treatment for Patients and Communities Act of 2018: Dispensing and Administering Controlled Substances for Medication-Assisted Treatment
Starting July 9, 2026, new rules make it easier for doctors and pharmacies to provide medicine that helps people recover from opioid addiction. These changes affect healthcare providers by expanding who can give medication-assisted treatment and how pharmacies can deliver these medicines. The goal? Faster, safer access to treatment with clear rules that save time and support recovery.
2026-10128 — Revision of Applications for Manufacturing and Procurement Quotas
The DEA wants to update how companies apply for permission to make and buy certain controlled drugs and chemicals. These changes will make the rules clearer, help prevent drug shortages, and ensure enough supply for medical and scientific needs. If you’re a manufacturer or involved in this process, get ready to follow new steps and share your thoughts by July 20, 2026.
2026-13988 — Frederick Tanzer, M.D.; Decision and Order
Dr. Frederick Tanzer from Ohio lost his DEA registration because he no longer has permission to handle controlled substances in his state. He didn’t ask for a hearing, so the DEA moved forward and officially revoked his registration. This means Dr. Tanzer can’t legally prescribe or handle certain drugs anymore, effective immediately.
2026-13991 — Ruth Jones, D.O.; Decision and Order
Ruth Jones, D.O., tried to get a DEA registration but was denied because she was convicted of serious drug-related crimes and banned from federal health programs. She missed the deadline to ask for a hearing, so the case was closed against her. This means she can’t legally handle controlled substances, affecting her medical practice and career.
2026-13989 — Mark Allen, D.D.S.; Decision and Order
Mark Allen, D.D.S., lost his DEA registration because he no longer has permission to handle controlled substances in Oklahoma. He didn’t ask for a hearing, so the DEA canceled his registration by default. This means he can’t legally prescribe or manage controlled drugs anymore, effective immediately, impacting his dental practice and any related income.
2026-13825 — Designation of Phenethyl Halides as List I Chemicals
The DEA wants to add phenethyl halides to a special list of chemicals that are closely watched because they can be used to make illegal fentanyl. This means anyone handling these chemicals will have to follow new rules starting soon, no matter how much they have. If you work with these chemicals, get ready to comply and share your thoughts by August 10, 2026!
Previous / Next Documents
Previous: 2026-13991 — Ruth Jones, D.O.; Decision and Order
Ruth Jones, D.O., tried to get a DEA registration but was denied because she was convicted of serious drug-related crimes and banned from federal health programs. She missed the deadline to ask for a hearing, so the case was closed against her. This means she can’t legally handle controlled substances, affecting her medical practice and career.
Next: 2026-13993 — Certain Pre-Stretched Synthetic Braiding Hair and Packaging Therefor; Notice of Commission Determination Not To Review an Initial Determination Terminating the Enforcement Proceeding Based on Withdrawal of the Enforcement Complaint; Termination of the Enforcement Proceeding
JBS Hair decided to drop their complaint against Vivace about synthetic braiding hair, so the U.S. International Trade Commission ended the enforcement case. This means Vivace won’t face any penalties or restrictions related to this issue. If you’re in the hair product business, no changes or costs are coming from this case anymore.